Search For "biotech"
Lancet Infectious Diseases study compare well with phase 3 clinical trials
Updated : 4 years, 3 months ago IST
New Delhi [India], November 25 (ANI): Commenting on the study of the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against symptomatic RT-PCR, the Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obt
Read More
Covaxin true success story of public-private partnership, says Bharat Biot
Updated : 4 years, 3 months ago IST
New Delhi [India], November 24 (ANI): The development of the country's indigenous COVID-19 vaccine Covaxin is a true success story for public-private partnerships in India, which is based on mutual respect, trust and transparency, said Dr Krishna Ella, Chairman and Managing Director, Bharat
Read More
Oravax and Genomma Lab announce JV to commercialize oral COVID-19 vaccine
Updated : 4 years, 3 months ago IST
Gurugram (Haryana) [India], November 20 (ANI/BusinessWire India): Premas Biotech together with their partners Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, and Genomma Lab In
Read More
COVID-19: Bahrain approves Bharat Biotech's Covaxin
Updated : 4 years, 4 months ago IST
Manama [Bahrain], November 12 (ANI): Bahrain has approved the emergency use of India's indigenously developed COVID-19 vaccination--Covaxin.
Read More
Bharat Biotech's Covaxin phase 3 data shows 77.8 pc efficacy against COVID
Updated : 4 years, 4 months ago IST
Hyderabad (Telangana) [India], November 12 (ANI): Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech's Covaxin.
Read More
Booster dose of COVID-19 vaccine required if virus gets mutated, says Bhar
Updated : 4 years, 4 months ago IST
New Delhi [India], November 11 (ANI): People will need booster doses of the COVID-19 vaccine if the COVID-19 virus gets mutated, said Chairman and Managing Director of Bharat Biotech, Dr Krishna Ella.
Read More
Hong Kong approves Bharat Biotech's Covaxin
Updated : 4 years, 4 months ago IST
Hong Kong, November 10 (ANI): Hong Kong has recognised Hyderabad-based pharmaceutical firm Bharat Biotech's Covaxin on its approved COVID-19 vaccine list.
Read More
Covaxin for Children will take some more time for final approval: Sources
Updated : 4 years, 4 months ago IST
New Delhi [India], November 8 (ANI): The data for Bharat Biotech's Covaxin for Children, COVID-19 vaccine, is under evaluation and the process will take some more time for final approval from the Drugs Controller General of India (DCGI), sources said.
Read More
Chinese fertilizer company demands USD 8 million from Sri Lankan authoriti
Updated : 4 years, 4 months ago IST
Beijing [China], November 8 (ANI): Qingdao Seawin Biotech Group Co Ltd, the Chinese company involved in a controversy with Sri Lanka over imported fertilizer, has demanded USD 8 million from the Additional Director of the National Plant Quarantine Service (NPQS) of Sri Lanka for the loss and
Read More
Bharat Biotech's partner seeks Covaxin approval in US for children below 1
Updated : 4 years, 4 months ago IST
New Delhi [India], November 6 (ANI): Bharat Biotech's US partner Ocugen has announced that it had asked the US Food and Drug Administration (FDA) for Emergency Use Authorisation (EUA) of Covaxin for children below 18.
Read More
WHO EUL approval opens up Covaxin for worldwide use: ICMR DG
Updated : 4 years, 4 months ago IST
New Delhi [India], November 4 (ANI): Following the World Health Organization's (WHO) Emergency Use Listing (EUL) for Bharat Biotech's COVID-19 vaccine, Covaxin, Indian Council of Medical Research (ICMR) Director General Balram Bhargava on Wednesday said the approval has now opened up the ind
Read More
WHO Regional Director congratulates India for emergency use listing of Cov
Updated : 4 years, 4 months ago IST
Geneva [Switzerland], November 3 (ANI): World Health Organisation's South-East Asia Regional Director Dr Poonam Khetrapal Singh has congratulated India on the Emergency Use Listing of Bharat Biotech's COVID-19 vaccine Covaxin on Wednesday.
Read More